Secukinumab earns FDA approval for plaque psoriasis

The U.S. Food and Drug Administration has approved secukinumab for the treatment of moderate to severe plaque psoriasis in adults. The injectable interleukin-17A inhibitor is indicated for...

Field of Interest: Dermatology
Type: News Item

Antibody hallmark for lupus challenged by study

The findings of a new study challenge the importance of anti–double stranded DNA antibodies as a diagnostic hallmark for lupus. The assessment of different anti–double stranded DNA (dsDNA) antibody...

Field of Interest: Dermatology
Type: News Item

Antibody hallmark for lupus challenged by study

The findings of a new study challenge the importance of anti–double stranded DNA antibodies as a diagnostic hallmark for lupus. The assessment of different anti–double stranded DNA (dsDNA) antibody...

Field of Interest: Rheumatology
Type: News Item

FDA approves topical ivermectin for rosacea

The Food and Drug Administration has approved a topical formulation of ivermectin for the once-daily topical treatment of inflammatory lesions related to rosacea. The drug will be marketed as...

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness